These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12423000)

  • 1. Effects of oxidizing adulterants on detection of 11-nor-delta9-THC-9-carboxylic acid in urine.
    Paul BD; Jacobs A
    J Anal Toxicol; 2002 Oct; 26(7):460-3. PubMed ID: 12423000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrophotometric detection of iodide and chromic (III) in urine after oxidation to iodine and chromate (VI).
    Paul BD; Jacobs A
    J Anal Toxicol; 2005 Oct; 29(7):658-63. PubMed ID: 16419396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papain: a novel urine adulterant.
    Burrows DL; Nicolaides A; Rice PJ; Dufforc M; Johnson DA; Ferslew KE
    J Anal Toxicol; 2005; 29(5):275-95. PubMed ID: 16105251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine pH, container composition, and exposure time influence adsorptive loss of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Jamerson MH; McCue JJ; Klette KL
    J Anal Toxicol; 2005 Oct; 29(7):627-31. PubMed ID: 16419391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study.
    Fraser AD; Worth D
    Forensic Sci Int; 2003 Nov; 137(2-3):196-202. PubMed ID: 14609657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.
    ElSohly MA; deWit H; Wachtel SR; Feng S; Murphy TP
    J Anal Toxicol; 2001 Oct; 25(7):565-71. PubMed ID: 11599601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six spectroscopic methods for detection of oxidants in urine: implication in differentiation of normal and adulterated urine.
    Paul BD
    J Anal Toxicol; 2004 Oct; 28(7):599-608. PubMed ID: 15516320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in traffic fatality cases.
    Lin DL; Lin RL
    J Anal Toxicol; 2005; 29(1):58-61. PubMed ID: 15808015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase extraction of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid from urine drug-testing specimens with the cerex polycrom-THC column.
    Crockett DK; Nelson G; Dimson P; Urry FM
    J Anal Toxicol; 2000; 24(4):245-9. PubMed ID: 10872570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantification of low concentrations of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid from minimal amounts of urine.
    Musshoff F; Daldrup T
    Int J Legal Med; 1991; 104(5):263-6. PubMed ID: 1664232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance evaluation of three on-site adulterant detection devices for urine specimens.
    Peace MR; Tarnai LD
    J Anal Toxicol; 2002 Oct; 26(7):464-70. PubMed ID: 12423001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
    J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
    Moody DE; Monti KM; Crouch DJ
    J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous analysis of delta9-THC and its major metabolites in urine, plasma, and meconium by GC-MS using an immunoaffinity extraction procedure.
    Feng S; ElSohly MA; Salamone S; Salem MY
    J Anal Toxicol; 2000 Sep; 24(6):395-402. PubMed ID: 10999345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase extraction and GC-MS analysis of THC-COOH method optimized for a high-throughput forensic drug-testing laboratory.
    Stout PR; Horn CK; Klette KL
    J Anal Toxicol; 2001 Oct; 25(7):550-4. PubMed ID: 11599598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adulterants in Urine Drug Testing.
    Fu S
    Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in a urine-based standard reference material by isotope-dilution liquid chromatography-mass spectrometry with electrospray ionization.
    Tai SS; Welch MJ
    J Anal Toxicol; 2000 Sep; 24(6):385-9. PubMed ID: 10999343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid quantification of urinary 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid using fast gas chromatography-mass spectrometry.
    Jamerson MH; Welton RM; Morris-Kukoski CL; Klette KL
    J Anal Toxicol; 2005 Oct; 29(7):664-8. PubMed ID: 16419397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of 11 -nor-delta9-tetrahydrocannabinol-9-carboxylic acid with GC-MS in urine collected for doping analysis.
    De Cock KJ; Delbeke FT; De Boer D; Van Eenoo P; Roels K
    J Anal Toxicol; 2003 Mar; 27(2):106-9. PubMed ID: 12670005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.